F. B. Ruymann

Prognosis in children with rhabdomyosarcoma: a report of the intergroup rhabdomyosarcoma studies I and II. Intergroup Rhabdomyosarcoma Committee.

W M Crist, Lisa Garnsey, Mohan Beltangady et al. · Journal of Clinical Oncology · 1990 · 288 citations

Surgical Oncology, Oncology, Intergroup Rhabdomyosarcoma Studies +11

Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapy.

Thomas W. Pendergrass, Jerrold M. Milstein, J. Russell Geyer et al. · Journal of Clinical Oncology · 1987 · 218 citations

Pediatric Brain Tumors, Chemoprevention Strategy, Day Chemotherapy +23

Treatment of newly diagnosed children and adolescents with acute myeloid leukemia: a Childrens Cancer Group study.

Robert J. Wells, William G. Woods, Jonathan D. Buckley et al. · Journal of Clinical Oncology · 1994 · 131 citations

Hematological Malignancy, Oncology, Pediatric Epidemiology +13

Ifosfamide and Etoposide Are Superior to Vincristine and Melphalan for Pediatric Metastatic Rhabdomyosarcoma When Administered With Irradiation and Combination Chemotherapy: A Report From the Intergroup Rhabdomyosarcoma Study Group

Philip P. Breitfeld, Elizabeth Lyden, R. Beverly Raney et al. · ˜The œAmerican journal of pediatric hematology/oncology · 2001 · 94 citations

Efficacy of ifosfamide and doxorubicin given as a phase II “window” in children with newly diagnosed metastatic rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study Group*

Eric Sandler, Elizabeth Lyden, F. B. Ruymann et al. · Medical and Pediatric Oncology · 2001 · 82 citations